Biotron Limited Stock Analysis
| BITRF Stock | USD 0 0.00 0.00% |
Biotron Limited holds a debt-to-equity ratio of 0.07. Biotron's financial risk is the risk to Biotron stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Biotron's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Biotron's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Biotron Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Biotron's stakeholders.
For many companies, including Biotron, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Biotron Limited, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Biotron's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Biotron's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Biotron is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Biotron to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Biotron is said to be less leveraged. If creditors hold a majority of Biotron's assets, the Company is said to be highly leveraged.
Biotron Limited is overvalued with Real Value of 0.00288 and Hype Value of 0.002781. The main objective of Biotron pink sheet analysis is to determine its intrinsic value, which is an estimate of what Biotron Limited is worth, separate from its market price. There are two main types of Biotron's stock analysis: fundamental analysis and technical analysis.
The Biotron pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biotron's ongoing operational relationships across important fundamental and technical indicators.
Biotron |
Biotron Pink Sheet Analysis Notes
About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Biotron Limited had not issued any dividends in recent years. The entity had 140:127 split on the 15th of May 2018. Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Biotron Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Biotron Limited please contact the company at 61 2 9300 3344 or go to https://www.biotron.com.au.Biotron Limited Investment Alerts
| Biotron Limited is way too risky over 90 days horizon | |
| Biotron Limited has some characteristics of a very speculative penny stock | |
| Biotron Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.56 M. Net Loss for the year was (2.78 M) with profit before overhead, payroll, taxes, and interest of 1.56 M. | |
| Biotron Limited has accumulated about 1.74 M in cash with (2.44 M) of positive cash flow from operations. | |
| Roughly 14.0% of the company shares are held by company insiders |
Biotron Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotron's market, we take the total number of its shares issued and multiply it by Biotron's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biotron Profitablity
The company has Profit Margin (PM) of (1.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.78.Technical Drivers
As of the 11th of February 2026, Biotron shows the Mean Deviation of 50.58, risk adjusted performance of 0.0958, and Standard Deviation of 209.19. Biotron Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Biotron Limited variance and skewness to decide if Biotron Limited is priced correctly, providing market reflects its regular price of 0.003 per share. As Biotron Limited appears to be a penny stock we also recommend to validate its information ratio numbers.Biotron Limited Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Biotron price series with the more recent values given greater weights.
Biotron Predictive Daily Indicators
Biotron intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biotron pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Biotron Forecast Models
Biotron's time-series forecasting models are one of many Biotron's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotron's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Biotron Limited Debt to Cash Allocation
Many companies such as Biotron, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Biotron Limited has accumulated 77.24 K in total debt with debt to equity ratio (D/E) of 0.07, which may suggest the company is not taking enough advantage from borrowing. Biotron Limited has a current ratio of 2.3, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biotron until it has trouble settling it off, either with new capital or with free cash flow. So, Biotron's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotron Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotron to invest in growth at high rates of return. When we think about Biotron's use of debt, we should always consider it together with cash and equity.Biotron Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biotron's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biotron, which in turn will lower the firm's financial flexibility.About Biotron Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Biotron prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotron shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Biotron. By using and applying Biotron Pink Sheet analysis, traders can create a robust methodology for identifying Biotron entry and exit points for their positions.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Biotron to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Complementary Tools for Biotron Pink Sheet analysis
When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |